ZBTB16 and Hyperglycemia: Liver-specific knockdown of Zbtb16 relieved hyperglycemia in db/db mice and led to decreased insulin levels, improved glucose and pyruvate tolerance, and insulin sensitivity (Chen et al., 2014).